Announcements
On 6 June 2017, the World Health Organization (WHO) published updates to its ‘Essential Medicines List’ (EML). Read more here.

Extended deadline (from 1 July to 31 July) 2017 for call to submit papers on effectiveness and cost-effectiveness of screening and prevention of infectious diseases among newly arrived migrants in Europe. Read more here.

Eurosurveillance is on the updated list of the Directory of Open Access Journals and in the SHERPA/RoMEO database. Read more here.

Follow Eurosurveillance on Twitter: @Eurosurveillanc


In this issue


Home Eurosurveillance Monthly Release  2006: Volume 11/ Issue 9 Article 2
Back to Table of Contents
en es fr
Previous
Next

Eurosurveillance, Volume 11, Issue 9, 01 September 2006
Outbreak report
Un brote decreciente de LGV en los Países Bajos en 2004 y 2005

Citation style for this article: van de Laar MJ, Koedijk FD, Götz H, de Vries HJ. Un brote decreciente de LGV en los Países Bajos en 2004 y 2005. Euro Surveill. 2006;11(9):pii=642. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=642

 

MJW van de Laar1, FDH Koedijk1, HM. Gotz2, HJC de Vries3
1 Centre for Infectious Disease Control, National Institute of Public Health and the Environment, Bilthoven, Países-Bajos
2 Municipal Health Service Rotterdam and environments, Rotterdam, Países-Bajos
3 Department of Dermatology, Academic Medical Centre, University of Amsterdam, and STI outpatient clinic, Health Service Amsterdam, Amsterdam, Países-Bajos

 


En 2004, se detectó un brote de LGV en hombres homosexuales en los Países Bajos. En enero de 2006, se habían declarado 179 casos confirmados de LGV : 65 retrospectivamente en 2002/2003, 76 en 2004 y 38 en 2005.
La evolución del brote de LGV parece ser descendente y solamente se ha identificado un pequeño número de casos durante los primeros meses de 2006.

 
El artículo completo está disponible en inglés

 

 



Back to Table of Contents
en es fr
Previous
Next

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN] - ©2007-2016. All rights reserved
 

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.